BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 16, 2001
View Archived Issues
Beta-amyloid peptide causes cognitive loss in AD via nicotinic receptor block
Read More
Id4 identified as regulator of BRCA1 expression
Read More
Novel cell-based transplantation therapy investigated for MS
Read More
NS-7 for both acute and chronic sequelae of cerebral ischemia
Read More
Initial results from pivotal trial of Cubist's Cidecin announced
Read More
Merck's second-generation HRT patch receives positive opinion in E.U.
Read More
Thrombin inhibition with PEG-hirudin as a new approach to the therapy of arthritis
Read More
XTL purchases stake in iviGene, gains access to technology
Read More
New safety information for miconazole vaginal cream and suppositories mandated by FDA
Read More
Beneficial effects of simvastatin independent of its cholesterol-lowering action
Read More
Argatroban enters phase II for ischemic stroke
Read More
XV-454 compares favorably to abciximab in flow models of thrombosis in vitro
Read More
Marketing application filed in Australia for PhotoCure's Metvix PDT
Read More
E.C. approves Rapamune for immunosuppression following renal transplantation
Read More
Bioenvision announces codevelopment partner for clofarabine
Read More
Pneumococcal vaccines claimed by Erasmus University
Read More
Modified erythropoietin with increased biological activity
Read More
Chymase-inhibitory thiazine and pyrazine derivatives under study at Santen
Read More
Potent and selective 5-ht6 receptor antagonists and their use described by NPS Allelix
Read More
Sumitomo presents new agents for immune and inflammatory disorders
Read More
Somatostatin receptor modulators designed at SCRAS
Read More
Draximage obtains license to infection imaging agent
Read More